 Life expectancy patients chronic nonleukemic myeloproliferative disorders study frame current therapeutic possibilities impact chronic nonleukemic myeloproliferative disorders survival survival data patients polycythemia vera essential thrombocythemia idiopathic myelofibrosis Spanish institutions actuarial survival probability group patients age-matched sex-matched control population survival patients polycythemia vera essential thrombocythemia control population survival patients idiopathic myelofibrosis respect control population terms survival current therapeutic procedures satisfactory patients polycythemia vera essential thrombocythemia hand due poor survival patients idiopathic myelofibrosis new therapeutic approaches condition